These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35377522)

  • 1. Tumor-derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer.
    Shi W; Zhang F; Chen X; Wang S; Zhang H; Yang Z; Wang G; Zheng Y; Han Y; Sun Y; Gao A
    Cancer Sci; 2022 Jun; 113(6):1939-1954. PubMed ID: 35377522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression.
    Yang Z; Gao A; Shi W; Wang J; Zhang X; Xu Z; Xu T; Zheng Y; Sun Y; Yang F
    Onco Targets Ther; 2021; 14():4239-4254. PubMed ID: 34321889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL8 induces M2 macrophage polarization and inhibits CD8
    Shao Y; Lan Y; Chai X; Gao S; Zheng J; Huang R; Shi Y; Xiang Y; Guo H; Xi Y; Yang L; Yang T
    FASEB J; 2023 Oct; 37(10):e23173. PubMed ID: 37665572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer.
    Hong SM; Lee AY; Kim BJ; Lee JE; Seon SY; Ha YJ; Ng JT; Yoon G; Lim SB; Morgan MJ; Cha JH; Lee D; Kim YS
    Adv Sci (Weinh); 2024 Apr; 11(14):e2303177. PubMed ID: 38308188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 7. Silence of a dependence receptor CSF1R in colorectal cancer cells activates tumor-associated macrophages.
    Zhu M; Bai L; Liu X; Peng S; Xie Y; Bai H; Yu H; Wang X; Yuan P; Ma R; Lin J; Wu L; Huang M; Li Y; Luo Y
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
    Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
    Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infiltration of Apoptotic M2 Macrophage Subpopulation Is Negatively Correlated with the Immunotherapy Response in Colorectal Cancer.
    Liu R; Han C; Hu J; Zhang B; Luo W; Ling F
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
    Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BST2 induced macrophage M2 polarization to promote the progression of colorectal cancer.
    He X; Chen H; Zhong X; Wang Y; Hu Z; Huang H; Zhao S; Wei P; Shi D; Li D
    Int J Biol Sci; 2023; 19(1):331-345. PubMed ID: 36594082
    [No Abstract]   [Full Text] [Related]  

  • 13. Low level of stromal lectin-like oxidized LDL receptor 1 and CD8
    Katayama C; Yokobori T; Ozawa N; Suga K; Shiraishi T; Okada T; Osone K; Katoh R; Suto T; Motegi Y; Ogawa H; Sano A; Sakai M; Sohda M; Erkhem-Ochir B; Gombodorj N; Katayama A; Oyama T; Shirabe K; Kuwano H; Saeki H
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1364. PubMed ID: 33675293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ID1 expressing macrophages support cancer cell stemness and limit CD8
    Shang S; Yang C; Chen F; Xiang RS; Zhang H; Dai SY; Liu J; Lv XX; Zhang C; Liu XT; Zhang Q; Lu SB; Song JW; Yu JJ; Zhou JC; Zhang XW; Cui B; Li PP; Zhu ST; Zhang HZ; Hua F
    Nat Commun; 2023 Nov; 14(1):7661. PubMed ID: 37996458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin-Like Transcript 5 Inhibits Macrophage-Mediated Bacterial Killing and Antigen Presentation During Sepsis.
    Ming S; Li M; Wu M; Zhang J; Zhong H; Chen J; Huang Y; Bai J; Huang L; Chen J; Lin Q; Liu J; Tao J; He D; Huang X
    J Infect Dis; 2019 Oct; 220(10):1688-1699. PubMed ID: 31250008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment.
    Li C; Song J; Guo Z; Gong Y; Zhang T; Huang J; Cheng R; Yu X; Li Y; Chen L; Ma X; Sun Y; Wang Y; Xue L
    Front Immunol; 2022; 13():857808. PubMed ID: 35432300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis.
    Fang H; Huang Y; Luo Y; Tang J; Yu M; Zhang Y; Zhong M
    Cell Immunol; 2022 Jan; 371():104458. PubMed ID: 34847407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.